Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two maintenance doses of caffeine citrate on patent ductus arteriosus in very low birth weight infants
IRCT20240929063204N1Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of caffeine in patent ductus arteriosus (PDA) (2 arms), sponsored by Babol University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
caffeine
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20240929063204N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063204N1.